3rd Circ. Ruling Isn't Last Word On Noncash Pay-For-Delay

By Melissa Lipman (June 26, 2015, 8:37 PM EDT) -- The Third Circuit answered the initial question Friday of whether pay-for-delay deals have to include cash to face antitrust scrutiny when it revived a class action over a brand's promise not to launch an authorized generic, but attorneys say it's far from clear that pharmaceutical patent settlements using other alternatives to cash payouts would have the same fate....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!